Insider Transactions in Q2 2024 at Jasper Therapeutics, Inc. (JSPR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
Jeetinder Singh Mahal Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
900
-3.47%
|
$21,600
$24.16 P/Share
|
|
Jun 12
2024
|
Jeetinder Singh Mahal Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+3.36%
|
$6,300
$7.1 P/Share
|
|
Jun 07
2024
|
Edwin Jonathan Tucker Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+50.0%
|
$1,600
$4.17 P/Share
|